期刊文献+

右美托咪啶对婴幼儿体外循环心脏手术全身炎性反应的影响 被引量:1

The Anti-inflammatory Effect of Dexmedetomidine in Pediatric Open Heart Surgery under Cardiopulmonary Bypass
原文传递
导出
摘要 目的观察右美托咪啶对婴幼儿体外循环心脏手术围术期全身炎性反应的影响。方法选择行体外循环心脏矫治手术的1-3岁小儿常见简单先天性病患者80例,随机分为右美托咪啶组和对照组各40例。右美托咪啶组在麻醉诱导插管并建立中心静脉后静脉泵入负荷量右美托咪啶4ug/kg*h持续15分钟,之后维持剂量调节为0.5ug/kg*h至手术结束,对照组同时间静脉泵入等容量生理盐水。分别于体外循环前(T0)、结束(T1)、术后6h(T2)、术后24小时(T3)抽取中心静脉血,测定血清中肿瘤坏死因子(TNF-α)和白细胞介素6(IL-6)、白细胞介素10(IL-10)的含量。结果两组体外循环前TNF-α、IL-6、IL-10无统计学意义(P>0.05),体外循环后两组TNF-α、IL-6、IL-10较体外循环前均明显增高,至T2达最高峰(P<0.01);与对照组相比,右美托咪啶组T1、T2、T3时间点TNF-α和IL-6均降低(P<0.01),而IL-10升高(P<0.01)。结论右美托咪啶可减轻婴幼儿体外循环心脏手术期间全身炎性反应程度,降低血浆中促炎因子TNF-α和IL-6浓度、增加抑炎因子IL-10浓度。 Objective To observe the anti-inflammatory effect of dexmedetomidine in pediatric open heart surgery under cardiopulmonary bypass. Methods 100 pediatric patients suffered open heart surgery were randomly divided into 2 groups, the dexmedetomidine (n=50) and the control group (n=50). The drugs were given by two stages, first injection at 4ug/kg*h for 15 min, and then maintained at 0.5ug/kg*h until the operation finished. TNF-α, IL-6 and IL-10 were determined with the central venous blood that extracted before the cardiopulmonary bypass (T0),at the time of cardiopulmonary bypass finished (T1), and 6, 24h at postoperative (T2 ,T3). Results The difference of TNF-α, IL-6, IL-10 were not statistically significant (P 〉 0.05) before the cardiopulmonary bypass. TNF-α、 IL-6 and IL-10 were significantly increased after cardiopulmonary bypass and further increased at T2 time in both the two groups ; Compared with the control group, the TNF-α and IL-6 were decreased at the T1, T2 and T3 time while the IL-10 were increased in dexmedetomidine group. Conclusion Dexmedetomidine has obivious anti-inflammatory effect in the pediatric open heart surgery under cardiopulmonary bypass. It can decrease the release of TNF-α and IL-6 and increase the secretion of IL-10.
出处 《中国分子心脏病学杂志》 CAS 2015年第4期1373-1376,共4页 Molecular Cardiology of China
基金 河北省卫计委医学科学研究课题计划项目(20150731)
关键词 体外循环 炎性反应 婴幼儿 右美托咪啶 Cardiopulmonary Bypass Inflammatory Response Pediatric Dexmedetomidine
  • 相关文献

参考文献16

  • 1Izuha H, Hattori M, lgari T, et al. Changes in platelet aggregation during cardiopulmonary bypass: comparison of poly-2- methoxyethylacrylate and heparin as a circuit coating material. J Artif Organs 2005;8:41-46.
  • 2Holmes JHt, Connolly NC, Paull DL, et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes, lnflamm Res 2002;51:579-586.
  • 3Billiau A, Vandekerckhove F. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest 1991;21:559-573.
  • 4Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885- 891.
  • 5Dumon K, Rossbach C, Harms B, et al. [Tumor necrosis factor- alpha (TNF-alpha) gene polymorphism in surgical intensive care patients with SIRS]. Langenbecks Arch Chip" Suppl Kongressbd 1998;115:387-390.
  • 6Oda S, Hirasawa H, Shiga H, et al. Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis. Cytokine 2005;29:169-175.
  • 7Zhang WR, Garg AX, Coca SG, et al. Plasma IL-6 and IL-10 Concentrations Predict AKI and Long-Term Mortality in Adults after Cardiac Surgery. J Am Soc Nephro12015.
  • 8Chew MS, Brandslund 1, Brix-Christensen V, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiolog3" 2001;94:745-753; discussion 745A.
  • 9Deng C, Zhai Z, Wu D, et al. Inflammatory response and pneumocyte apoptosis during lung ischemia-reperfusion injury in an experimental pulmonary thromboembolism model. J Thromb Thrombol)'sis 2015.
  • 10Zhang X, Zhao X, Wang Y. Dexmedetomidine: a review of applications for cardiac surgery during perioperative period. J Anesth 2015;29:102-111.

二级参考文献14

  • 1尹光明,喻田,余志豪.核因子kappa B与体外循环炎性反应[J].国外医学(麻醉学与复苏分册),2004,25(6):353-356. 被引量:12
  • 2李叙,范士志,李志平,蒋耀光.体外循环围手术期白细胞、中性粒细胞与细胞因子变化关系研究[J].重庆医学,2005,34(8):1167-1168. 被引量:10
  • 3Baehner T, Boehm O, Probst C, et al. Cardiopulmonary bypass in cardiac surgery [J] Anaesthesist, 2012, 61 (10) :846-856.
  • 4Levy JH,Tanaka KA. Inflammatory response to cardiop- ulmonary bypass [J]. Ann Thorac Surg, 2003, 75 (2): $715-720.
  • 5Jouan J,Golmard L, Benhamouda N, et al. Gene polymor- phisms and cytokine plasma levels as predictive factors of complications after cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg, 2012,144 (2) : 467 473.
  • 6Xie GQ, Jiang JX, ChenYH, et al. Induction of acute he- patic injury by endotoxin in mice[J]. Hepatobiliary Pan- creat Dis Int,2002,1(4) :558-564.
  • 7Li T,Luo N,Du L,et al. Early and marked up-regulation of TNF-: in acute respiratory distress syndrome after car- diopulmonary bypass [J]. Front Mecl, 2012, 6 (3) : 296- 301.
  • 8Mojcik CF, Levy JH. Aprotinin and the systemic inflam.matory response after cardiopulmonary bypass [J]. Ann Thorac Surg, 2001,71(2) : 745-754.
  • 9Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis:an a priori-designed analysis of the MENDS randomized controlled trial[J]. Crit Care, 2010, 14 (2) : R38.
  • 10Hofer S, Steppan J. Central sympatholytics prolong sur- vival in experimental sepsis [J]. Critical Care, 2009, 13 (1) .. Rll.

共引文献12

同被引文献30

  • 1YUEN VM, HUI TW, IRWIN MG, et al. A comparison of in- tranasal dexmedctomidine and oral midazo|am for premedication in pediatric anesthesia: a double-blinded randomized controlled trial[J]. AnesthAnalg, 2008, 106(6): 1715-1721.
  • 2CIMEN ZS, HANCI A, SIVRIKAYA GU, et al. Comparison ofbuccal and nasal dexmedetomidine premedication for pediatric pa- tients [ J ]. Paediatr Anaesth, 2013, 23 (2) : 134 - 138.
  • 3GHALI AM, MAHFOUZ AK, AL-BAHRANI M. Preanesthetic medication in children: a comparison of intranasal dexmedetomi- dine versus oral midazolam [ J ]. Saudi J Anaesth, 2011, 5 (4) : 387 - 391.
  • 4WANG SS, ZHANG MZ, SUN Y, et al. The sedative effects and the attenuation of cardiovascular and arousal responses during an- esthesia induction and intubation in pediatric patients: a random- ized comparison between two different doses of preoperative in- tranasal dexmedetomidine [ J ]. Paediatr Anaesth, 2014, 24 ( 3 ) : 275 - 281.
  • 5YUEN VM, HUI TW, IRWIN MG, et al. Optimal timing for the administration of intranasal dexmedetomidine for premedication in ehildren[J]. Anaesthesia, 2010, 65(9): 922-929.
  • 6MASON KP, O'MAHONY E, ZURAKOWSKI D, et al. Effects of dexmedetomidine sedation on the EEG in children[ J]. Paedi- atr Anaesth, 2009, 19(12) : 1175 - 1183.
  • 7ARD J, DOYLE W, BEKKER A. Awake craniotomy with dexme- detomidine in pediatric patients [ J ]. J Neurosurg Anesthesiol, 2003, 15(3): 263-266.
  • 8TOBIAS JD. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology [ J]. Pediatr Crit Care Med, 2007, 8(2): 115 -131.
  • 9TOBIAS JD, BERKENBOSCH JW. Initial experience with dexmedetomidine in paediatric-aged patients [ J ]. Paediatr An- aesth, 2002, 12(2) : 171 - 175.
  • 10CHEN KZ, YE M, HU CB, et al. Dexmedetomidine vs remifen- tanil intravenous anaesthesia and spontaneous ventilation for air- way foreign body removal in children[ J]. Br J Anaesth, 2014, 112(5) : 892 -897.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部